See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Cytovance Biologics secures $20M Credit

Cytovance Biologics, an 11-year-old, Oklahoma City, Ok.-based biopharmaceutical contract manufacturer that specializes in the production of therapeutic proteins and antibodies, has secured a $20 million credit facility from Monroe Capital.


More from